Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-14

Clinical Trial Update: The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure

View source ↗

Summary

A completed trial update evaluating the diurnal and nocturnal effects of Simbrinza and Timolol on intraocular pressure and ocular perfusion pressure in Open-ang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simbrinza (brinzolamide/brimonidine)
  • Timolol (timolol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Open Angle Glaucoma, Ocular Hypertension | Status: COMPLETED